Dexcom, Inc. v. Abbott Diabetes Care, Inc., No. 23-1795 (Fed. Cir. Jan. 3, 2024)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

This is an interlocutory appeal from a consolidated case between Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (collectively, “Abbott”) and DexCom, Inc. in the United States District Court for the District of Dela- ware. After DexCom sued Abbott for infringing its patents, Abbott petitioned for inter partes review of the asserted pa- tents before the Patent Trial and Appeal Board.